Literature DB >> 33673195

Coumarins from Seseli devenyense Simonk.: Isolation by Liquid-Liquid Chromatography and Potential Anxiolytic Activity Using an In Vivo Zebrafish Larvae Model.

Jarosław Widelski1, Simon Vlad Luca2,3, Adrianna Skiba4, Monika Maciąg5,6, Barbara Budzyńska5, Laurence Marcourt7, Jean-Luc Wolfender7, Krystyna Skalicka-Woźniak4.   

Abstract

Different types of anxiety disorders have become the number one mental health issue in developed countries. The search for new, safer and effective drug-like molecules among naturally derived substances faces two difficulties: an efficient method of isolation compounds with a high-purity and high-throughput animal model for activity assay. Thus, the aim of the present study was to isolate by liquid-liquid chromatography high-purity rare coumarins from the fruits of Seseli devenyense Simonk. and evaluate their anxiolytic effect (defined as reversed thimotaxis) using a 5-days post-fertilization (dpf) Danio rerio larvae model. Liquid-liquid chromatography enabled the isolation of one simple hydroxycoumarin (devenyol) and four pyranocoumarins (cis-khellactone, d-laserpitin, isolaserpitin and octanoyllomatin). The anxiolytic effect was defined as a decrease in the time spent in the boundaries of the living space (also described as reversed thigmotaxis). Our results show that all isolated courmarins exerted a significant influence on the anxiety behavior (anxiolytic activity) in the zebrafish larvae model. According to our knowledge, this is the first report of anxiolytic activity of pyranocoumarins and devenyol.

Entities:  

Keywords:  Apiaceae; Danio rerio; Seseli devenyense; anxiety; central nervous system; countercurrent chromatography

Mesh:

Substances:

Year:  2021        PMID: 33673195      PMCID: PMC7918798          DOI: 10.3390/ijms22041829

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  40 in total

1.  Isolation of the minor and rare constituents from fruits of Peucedanum alsaticum L. using high-performance counter-current chromatography.

Authors:  Krystyna Skalicka-Woźniak; Tomasz Mroczek; Ian Garrard; Kazimierz Głowniak
Journal:  J Sep Sci       Date:  2012-04       Impact factor: 3.645

Review 2.  Operating mode and parameter selection in liquid-liquid chromatography.

Authors:  Raena Morley; Mirjana Minceva
Journal:  J Chromatogr A       Date:  2019-08-23       Impact factor: 4.759

Review 3.  Use of benzodiazepines in anxiety disorders.

Authors:  R I Shader; D J Greenblatt
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

Review 4.  [Neural organization of different types of fear: implications for the understanding of anxiety].

Authors:  Marcus Lira Brandão; Daniel Machado Vianna; Sueli Masson; Júlia Santos
Journal:  Braz J Psychiatry       Date:  2004-02-16       Impact factor: 2.697

5.  Coumarins from Angelica archangelica Linn. and their effects on anxiety-like behavior.

Authors:  Dinesh Kumar; Zulfiqar Ali Bhat; Vijender Kumar; M Y Shah
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-29       Impact factor: 5.067

Review 6.  Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders.

Authors:  Zhang-Jin Zhang
Journal:  Life Sci       Date:  2004-08-20       Impact factor: 5.037

Review 7.  Progress in the Chemistry of Naturally Occurring Coumarins.

Authors:  Satyajit D Sarker; Lutfun Nahar
Journal:  Prog Chem Org Nat Prod       Date:  2017

Review 8.  Animal models for screening anxiolytic-like drugs: a perspective.

Authors:  Michel Bourin
Journal:  Dialogues Clin Neurosci       Date:  2015-09       Impact factor: 5.986

Review 9.  Structure-Dependent Activity of Natural GABA(A) Receptor Modulators.

Authors:  Serhat Sezai Çiçek
Journal:  Molecules       Date:  2018-06-22       Impact factor: 4.411

10.  Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator.

Authors:  Ancy Joseph; Tran Thi Thu Thuy; Le Tat Thanh; Masayoshi Okada
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.